Immunohistochemistry (IHC) Market Size, Share, Segmentation, Trends, Growth Opportunities, and Forecast 2030

Immunohistochemistry (IHC) Market

Immunohistochemistry (IHC) Market - By Product (Antibodies, Kits, and Reagents), By End User (Hospitals, Academic, and Diagnostic Labs), By Application (Forensic, Diagnostics, and Research), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026

Published Date: 13-May-2021 Category: Biotechnology Report Format : PDF Pages: 120 Report Code: ZMR-6244 Status : Published

The global Immunohistochemistry (IHC) market accrued earnings worth approximately 1.8(USD Billion) in 2019 and is predicted to gain revenue of about 3.3 (USD Billion) by 2026, is set to record a CAGR of nearly 7.6% over the period from 2020 to 2026.

Immunohistochemistry (IHC) Market

The global Immunohistochemistry (IHC) market accrued earnings worth approximately 1.8(USD Billion) in 2019 and is predicted to gain revenue of about 3.3 (USD Billion) by 2026, is set to record a CAGR of nearly 7.6% over the period from 2020 to 2026. The report offers assessment and analysis of the Immunohistochemistry (IHC) market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2017 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion).

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Immunohistochemistry (IHC) Market : Synopsis

Immunohistochemistry or IHC is a technique that makes effective use of monoclonal & polyclonal antibodies for identifying particular kind of antigens in tissues, thereby identifying various types of diseases in the persons. The IHC technique is divided into two phases: i) preparation of slides & stages involved in the reaction and ii) interpreting & quantifying the gene expression that is derived. Additionally, Immunohistochemistry plays a pivotal role in scientific research activities and interpretation of differential diagnosis that cannot be determined through conventional analysis with the help of eosin and hematoxylin. It is also utilized in pathology, majorly in domains of pathology including hematopathology, oncologic pathology, and neuropathology. Furthermore, Immunohistochemistry is the combination of immunology & histology.

Immunohistochemistry (IHC) Market: Growth Dynamics

Surge in the occurrence of chronic ailments and rise in the drug discovery activities will manifest in the humungous growth of immunohistochemistry (IHC) industry over 2020-2026. Apart from this, massive need for diagnosing cancer, heart disorders, and other viral ailments such as Swine Flu, Bird Flu, and COVID has unleashed the significance of immunohistochemistry in the healthcare, thereby driving market trends. In addition to this, regulatory approvals as well as launching of new products will steer the expansion of immunohistochemistry (IHC) industry over the assessment timeline. Nonetheless, huge costs of automated IHC devices can badly hit the expansion of the market over the assessment timespan. However, a paradigm shift in the healthcare sector will drastically transform & turn the phase of market growth in the near future.

Furthermore, rise in the diagnostic units and clinics along with rise in the cases of life-threatening ailments will prop up the expansion of immunohistochemistry (IHC) market over 2020-2026. Surge in the cancer cases as well as bulging elderly population prone to chronic ailments will help the market explore new dimensions of growth in the foreseeable future.

Regional Landscape

Asia Pacific Market To Exude Fastest Growth Over 2020-2026

Untapped growth potential in the emerging economies of Asia Pacific zone will help the Immunohistochemistry (IHC) market enter a new phase of growth in the coming years. Surge in chronic disorders in India, South Korea, Bangladesh, China, Singapore, and Philippines have contributed immensely towards regional market size in the recent years. Population explosion and surge in geriatric population in the countries like India and China will proliferate the regional market expansion over the assessment period.

Competitive Landscape

Key players profiled in the study are Perkinelmer, Inc.; Thermo Fisher Scientific, Inc.; Agilent Technologies, Inc.; Danaher Corporation; F. Hoffmann-La Roche Ltd.; Cell Signaling Technology, Inc.; Merck KGaA; Bio-Rad Laboratories, Inc.; Bio SB; and Abcam plc. 

The global Immunohistochemistry (IHC) Market is segmented as follows:

By Product

  • Antibodies
  • Kits
  • REAGENTS

By End-User

  • Hospitals
  • Academic
  • Diagnostic Labs

By Application

  • Forensic
  • Diagnostic
  • Research

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

Surge in the occurrence of chronic ailments and rise in the drug discovery activities will manifest in the humungous growth of immunohistochemistry (IHC) industry over 2020-2026. Apart from this, massive need for diagnosing cancer, heart disorders, and other viral ailments such as Swine Flu, Bird Flu, and COVID has unleashed the significance of immunohistochemistry in the healthcare, thereby driving market trends. In addition to this, regulatory approvals as well as launching of new products will steer the expansion of immunohistochemistry (IHC) industry over the assessment timeline. In addition to this, a paradigm shift in the healthcare sector will drastically transform & turn the phase of market growth in the near future. Furthermore, rise in the diagnostic units and clinics along with rise in the cases of life-threatening ailments will prop up the expansion of immunohistochemistry (IHC) market over 2020-2026.

According to Zion market research report, the global Immunohistochemistry (IHC) market accrued earnings worth approximately 1.8(USD Billion) in 2019 and is predicted to gain revenue of about 3.3 (USD Billion) by 2026, is set to record a CAGR of nearly 7.6% over the period from 2020 to 2026.

Asia Pacific will record rapid growth over the estimated timeline. The regional market surge is due to Surge in chronic disorders in India, South Korea, Bangladesh, China, Singapore, and Philippines have contributed immensely towards regional market size in the recent years. Population explosion and surge in geriatric population in the countries like India and China will proliferate the regional market expansion over the assessment period.

The key market participants include Perkinelmer, Inc.; Thermo Fisher Scientific, Inc.; Agilent Technologies, Inc.; Danaher Corporation; F. Hoffmann-La Roche Ltd.; Cell Signaling Technology, Inc.; Merck KGaA; Bio-Rad Laboratories, Inc.; Bio SB; and Abcam plc. 

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed